Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent.

Pellini, Bruna; Chaudhuri, Aadel A

Pellini, Bruna; Chaudhuri, Aadel A.

Affiliation

Pellini B; Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Chaudhuri AA; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL.

J Clin Oncol ; 40(6): 567-575, 2022 02 20.

Article in En | MEDLINE | ID: mdl-34985936

Subject(s)

Carcinoma, Non-Small-Cell Lung/therapy; Circulating Tumor DNA/genetics; Lung Neoplasms/therapy; Biomarkers/blood; Carcinoma, Non-Small-Cell Lung/blood; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/secondary; Circulating Tumor DNA/blood; High-Throughput Nucleotide Sequencing; Humans; Lung Neoplasms/blood; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google